HomeIOBT • NASDAQ
IO Biotech Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.58M | 11.82% |
Net income | -22.42M | -15.23% |
Net profit margin | — | — |
Earnings per share | -0.32 | -16.55% |
EBITDA | -22.52M | -11.86% |
Effective tax rate | -0.66% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 37.09M | -68.57% |
Total assets | 45.74M | -64.31% |
Total liabilities | 19.31M | 52.16% |
Total equity | 26.42M | — |
Shares outstanding | 65.88M | — |
Price to book | 3.30 | — |
Return on assets | -99.55% | — |
Return on capital | -146.43% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -22.42M | -15.23% |
Cash from operations | -23.07M | 7.46% |
Cash from investing | -28.00K | -154.55% |
Cash from financing | — | — |
Net change in cash | -22.95M | 8.99% |
Free cash flow | -13.90M | 21.13% |
Previous close
$1.32
Day range
$1.26 - $1.35
Year range
$0.66 - $1.73
Market cap
85.65M USD
Avg Volume
184.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
79
